Latest & greatest articles for colorectal cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on colorectal cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on colorectal cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for colorectal cancer

81. Mediterranean diet adherence and risk of colorectal cancer: a systematic review and meta-analysis

Mediterranean diet adherence and risk of colorectal cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

82. Prevalence of oxaliplatin-induced peripheral neuropathy among colorectal cancer (CRC) survivors after completion of adjuvant chemotherapy: systematic review

Prevalence of oxaliplatin-induced peripheral neuropathy among colorectal cancer (CRC) survivors after completion of adjuvant chemotherapy: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

83. Physical activity interventions: state of the science for colorectal cancer survivors

Physical activity interventions: state of the science for colorectal cancer survivors Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

84. Polygenic risk prediction models for colorectal cancer: a systematic review

Polygenic risk prediction models for colorectal cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

85. What risk is carried and what are the consequences of dehydration or renal impairment following defunctioning ileostomy in patients undergoing major resection for colorectal cancer?

What risk is carried and what are the consequences of dehydration or renal impairment following defunctioning ileostomy in patients undergoing major resection for colorectal cancer? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

86. Biliary drainage for malignant biliary obstruction due to metastatic colorectal cancer: a systematic review

Biliary drainage for malignant biliary obstruction due to metastatic colorectal cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

87. The effect of laxative use on colorectal cancer risk: a systematic review and meta-analysis

The effect of laxative use on colorectal cancer risk: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

88. A systematic review of the association between BMI and colorectal cancer in younger population

A systematic review of the association between BMI and colorectal cancer in younger population Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

89. Effectiveness of various invitation methods to a colonoscopy in the early detection and prevention of colorectal cancer

Effectiveness of various invitation methods to a colonoscopy in the early detection and prevention of colorectal cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

90. The potentials of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a predictive biomarker for colorectal cancer: a systematic review and meta-analysis

The potentials of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a predictive biomarker for colorectal cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

91. The prognostic value of CRY1/2 in colorectal cancer: a systematic review and meta-analysis

The prognostic value of CRY1/2 in colorectal cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

92. The use of simulation modeling to inform health system and policy decision-making in colorectal cancer (CRC) screening delivery: a systematic review

The use of simulation modeling to inform health system and policy decision-making in colorectal cancer (CRC) screening delivery: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

93. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and colorectal cancer risk: a meta-analysis

TP53 and MDM2 gene polymorphisms, gene-gene interaction, and colorectal cancer risk: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

94. Association of oral anthraquinone laxatives and colorectal cancer and melanosis coli: protocol for a systematic review and meta-analysis

Association of oral anthraquinone laxatives and colorectal cancer and melanosis coli: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

95. Laparoscopic versus open resection for colorectal cancer and long-term non-oncological outcomes: a meta-analysis of randomized and non-randomized trials

Laparoscopic versus open resection for colorectal cancer and long-term non-oncological outcomes: a meta-analysis of randomized and non-randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

96. Systematic review of aspirin in the prevention of hereditary and sporadic colorectal adenoma and cancer

Systematic review of aspirin in the prevention of hereditary and sporadic colorectal adenoma and cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

97. Prescription of 5-fluorouracil/capecitabine versus S-1 and adverse drug events among colorectal cancer patients: a systematic review and meta-analysis

Prescription of 5-fluorouracil/capecitabine versus S-1 and adverse drug events among colorectal cancer patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

98. Interventions for increasing colorectal cancer screening uptake among African-American men: a systematic review and meta-analysis

Interventions for increasing colorectal cancer screening uptake among African-American men: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

99. Endoscopic screening is associated with reduced colorectal cancer mortality: a meta-analysis and systematic review

Endoscopic screening is associated with reduced colorectal cancer mortality: a meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

100. Reduced port laparoscopic colectomy (RPLC) versus conventional laparoscopic colectomy for the treatment of patients with colorectal cancer: a systematic review and meta-analysis

Reduced port laparoscopic colectomy (RPLC) versus conventional laparoscopic colectomy for the treatment of patients with colorectal cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO